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ABSTRACT
Background and study aims A variety of endoscopic
techniques are currently available for treatment of upper
gastrointestinal (UGI) anastomotic leaks; however, no defi-
nite consensus exists on the most appropriate therapeutic
approach. Our aim was to explore current management of
UGI anastomotic leaks.
Methods A survey questionnaire was distributed among
international expert therapeutic endoscopists regarding
management of UGI anastomotic leaks.
Results A total of 44% of 163 surveys were returned; 69%
were from gastroenterologists and 56% had >10 years of
experience. A third of respondents treat between 10 and
19 patients annually. Fifty-six percent use fully-covered
self-expandable metal stents as their usual first option;
80 % use techniques to minimize migration; 4 weeks was
the most common reported stent dwell time. Sixty percent
perform epithelial ablation prior to over-the-scope-clip
placement or suturing. Regarding endoscopic vacuum ther-
apy (EVT), 56% perform balloon dilation and intracavitary
EVT in patients with large cavities but small leak defects.
Regarding endoscopic septotomy, 56% consider a minimal
interval of 4 weeks from surgery and 90% consider the
need to perform further sessions. Regarding endoscopic in-
ternal drainage (EID), placement of two stents and shorter
stents is preferred. Persistent inflammation with clinical
sepsis was the definition most commonly reported for
endoscopic failure. EVT/stent placement and EVT/EID were
the therapeutic options most often chosen in patients with
previous oncologic surgery and previous bariatric surgery,
respectively.
Conclusions There is a wide variation in the management
of patients with UGI anastomotic leaks. Future prospective
studies are needed to move from an expert- to evidence-
and personalization-based care.
Supplementary material
Online content viewable at:
https://doi.org/10.1055/a-1005-6632
* Full list of collaborators ordered alphabetically at the end of the
article.
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Introduction
Gastrointestinal leaks are abnormal communications between
the intraluminal and extraluminal compartments as a result of
a defect in the integrity of the gastrointestinal wall [1]. They
usually occur due to defects at surgical suture sites, being asso-
ciated with a high risk of mortality and morbidity. Leaks are
responsible for the majority of surgical mortality [2–4]. In ad-
dition, delayed closure of leaks may result in chronic fistulae
formation, which are difficult to manage endoscopically.
Prevalence of upper gastrointestinal (UGI) anastomotic leaks
has increased in recent years. Leaks related to oncologic sur-
gery leaks have been reported in 8% to 26% after distal esopha-
gectomy and in 3% to 12% after total gastrectomy [3, 5]; baria-
tric surgery leaks have been reported in 2% to 5% of patients
after Roux-en-Y gastric bypass (RYGB) and in 1% to 2% after
sleeve gastrectomy [6, 7].
Treatment of UGI anastomotic leaks remains controversial,
as indications for surgical, conservative and endoscopic ther-
apy remain non-standardized. Traditionally, surgical therapy
has been the mainstay of treatment for anastomotic leaks;
however, it tends to be complex and is plagued by high rates
of morbidity [8]. Over the last decade, interventional endos-
copy has evolved as an effective and less invasive alternative to
primary surgery, changing the management paradigm for UGI
leaks. A variety of techniques are currently available to reestab-
lish the continuity of the digestive tract, prevent or treat infec-
tion related to the leak, prevent further contamination, drain
potential collections, and provide nutritional support [9]. Endo-
scopic options include stent placement (metallic, plastic and
biodegradable), endoscopic vacuum therapy (EVT), endoscopic
internal drainage (EID), through-the-scope [TTS] and over-the-
scope clips [OTSC], endoscopic suturing, endoscopic septot-
omy plus balloon dilation and tissue sealants [9]. Theoretically,
all of these can be used alone or with a multimodality ap-
proach, with the approach chosen being tailored to the clinical
and morphologic presentation but also largely institutional de-
pendent and based upon availability of devices and accessories.
Even though endoscopic therapy may be associated with an
improved outcome and better quality of life, there is no definite
▶ Fig. 1 a Clinical case 1: 52-year-old man with subcutaneous emphysema and respiratory insufficiency after Ivor-Lewis esophagectomy due to
esophagus squamous-cell carcinoma; chest CTwith oral contrast revealed a 12-cm intrathoracic collection with communication with the gastric
tube; upper endoscopy revealed a severe anastomotic leakage 29 cm from the incisors. b Clinical case 2: 42-year-old woman, body mass index
38 kg/m2, who underwent laparoscopic sleeve gastrectomy, without drain placement; 10 days later, she presented with a left pneumonia; chest
CT with oral contrast revealed a 4-cm intrathoracic collection with communication with the gastric tube; upper endoscopy revealed a 20-mm
anastomotic leakage 35 cm from the incisors; no stricture was present at the level of the incisura angularis. c Clinical case 3: 38-year-old man,
with a body mass index of 40 kg/m2, who underwent a Roux-en-Y gastric bypass, and presented 6 days later with fever and leukocytosis; CTwith
oral contrast revealed an 8 cm intraabdominal collection with communication with the gastric pouch; upper endoscopy revealed an anasto-
motic leakage 44 cm from the incisors; d Clinical case 4: 72-year-old man with recurrent leukocytosis and fever after total gastrectomy; CT with
oral contrast revealed contrast extravasation between the gastrointestinal lumen and the intra-abdominal cavity; upper endoscopy revealed a
severe anastomotic leakage 41 cm from the incisors.
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consensus on the most appropriate therapeutic approach in
management of UGI anastomotic leaks. The current study was
designed to explore the current practices in the management
of UGI anastomotic leaks of a panel comprising international
expert therapeutic endoscopists with experience in leaks to
help design and inform future prospective studies.
Methods
An online survey was developed to assess the opinion and prac-
tice of a panel of international expert therapeutic endoscopists
regarding management of UGI anastomotic leaks. The partici-
pants were selected based on publications published on
PubMed between January 2013 and April 2018 regarding endo-
scopic treatment of UGI anastomotic leaks. A total of 226 pub-
lications were found, corresponding to 182 different authors
with available emails (first, last or corresponding authors). The
survey was initially distributed, tested and optimized among 12
selected therapeutic endoscopists (ERP, AR, GD, GM, JD, JEvH,
JMC, MGN, MS, PE, VK and MAK). Nineteen of the 182 obtained
e-mail addresses were inactive. In August 2018, 163 partici-
pants were invited via an e-mail link to an online survey pro-
gramme (http://www.surveymonkey.com), followed by a total
of 3-weekly reminders.
The survey consisted of 35 opinion-probing questions (Ap-
pendix 1) and 4 short clinical cases (▶Fig. 1). With regard to
the clinical vignettes, participants were asked to choose one
option between the different endoscopic therapies available.
The final percentage in multiple-choice questions may ex-
ceed 100%, as several respondents have chosen more than
one answer. Average ranking (AR) in ▶Table1 and Supplemen-
tary Table 1 was calculated to determine which therapeutic
choice was most preferred overall. It was calculated as follows,
where “w=weight of ranked position” and “x = response count
for answer choice”; weights are applied in reverse:
Ideal patient characteristics for each endoscopic technique
were based on themajority of respondents’ answers (▶Table 2).
Data were collected non-anonymously and analyzed using
the graphical and analytical features of www.surveymonkey.
com and IBM SPSS Statistics, version 24.0 (IBM Corp., Armonk,
New York, United States). Answers were described as counts
and percentages for categorical variables. Continuous variables
were summarized as medians and range. Regarding respon-
dents who gave time ranges between treatment sessions, the
median value of each range was used to determine the total
median value.
This study was conducted according to the Declaration of
Helsinki. All authors reviewed and approved the final manu-
script.
Results
Participants and endoscopic therapies
characterization
A total of 163 surveys were sent and 71 (44%) were returned.
Twenty-five countries on five different continents were repre-
sented. Sixty-nine percent of the respondents (n=49) were
gastroenterologists, with the remaining 31% (n=22) being sur-
geons. Eighty-two percent of respondents (n =58) worked in
academic hospitals and 18% (n=13) in non-academic teaching
hospitals. The number of patients with anastomotic leaks treat-
ed within each therapeutic endoscopy unit in 1 year ranged
from 1 to 4 at nine centers (13%) to >40 at five hospitals (7%)
(▶Fig. 2). Respondents had a median of 10 years [1–36] of ex-
perience.
Placement of self-expandable metal stents (SEMS) was the
technique most available in each department (97%), followed
by OTSC (89%) and EID (79%) (▶Fig. 3). Stent placement was
























Stent placement 52.1% 32.4% 8.5% 4.2% – 1.4% – 70 6.3
Endoscopic vacuum
therapy
15.5% 14.1% 7% 7% 8.5% 15.5% 11.3% 56 4.1
Endoscopic suturing 1.4% 8.5% 9.9% 14.1% 11.3% 15.5% 11.3% 51 3.4
Tissue sealants 7% 5.6% 11.3% 14.1% 15.5% 21.1% 12.7% 62 3.4
Over-the-scope clips 4.2 % 16.9% 33.8% 21.1% 9.9% 2.8% 2.8% 65 4.6
Endoscopic septotomy
plus balloon dilation
2.8% 11.3% 4.2% 8.5% 15.5% 8.5% 16.9% 48 3.3
Endoscopic internal
drainage
16.9% 9.9% 21.1% 16.9% 14.1% – 2.8% 60 4.7
Not applicable – 1.4% 4.2% 14.1% 25.4% 35.2% 42.3%
x1w1 þ x2w2 þ x3w3 ::: xnwn
Total
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the technique most frequently used (AR: 6.3), followed by EID
(AR: 4.7), OTSC (AR: 4.6) and EVT (AR: 4.1) (▶Table1). AR for
each continent, specialty, years of experience and patients
treated per year are represented in Supplementary Table1.
Leaks characteristics
Location (94%), size (93%), chronicity (91%) and associated
cavity (90%) were the most relevant characteristics considered
by respondents to impact choice of treatment. Sixty-five per-
cent of the respondents treat bariatric leaks differently from
oncologic surgery leaks. Collections not reachable by endos-
copy (69%) and insufficient internal drainage (66%) were the
most common indications for need for additional percuta-
neous/surgical drainage (Supplementary Table 2).
Self-expandable stents
Fifty-six percent of the 69 respondents with stent experience
reported fully-covered SEMS (FC-SEMS) to be their usual first
option, while 42% preferred partially-covered SEMS (PC-
▶ Table 2 Ideal patient characteristics for each endoscopic technique.
Ideal patient characteristics1
Stent OTSC EVT Suture Septotomy EID
Time of leak
▪ Acute 93.8% 96.8% 48.7% 89.5% 3.2% 54.3%
▪ Chronic 17.2% 19% 71.8% 31.6% 100% 65.2%
▪ NO/NI n =7 n=8 n=32 n=33 n=40 n =25
Leak size
▪ 0–1 cm 54.1% 77% 25% 64.7% 51.9% 63.6%
▪ 1–2 cm 63.9% 47.5% 40% 50% 63% 65.9%
▪ 2–3 cm 55.7% 9.8% 67.5% 47.1% 51.9% 45.5%
▪ >3 cm 42.6% – 77.5% 35.3% 63% 38.6%
▪ NO/NI n =10 n=10 n=31 n=37 n=44 n =27
Leak location
▪ Intrathoracic 93.2% 64% 92.5% 58.6% 25% 66%
▪ Intraabdominal 45.8% 92% 60% 96.6% 92.9% 83%
▪ NO/NI n =12 n=21 n=31 n=42 n=43 n =24
Associated collection
▪ Yes 11.3% 7% 95.2% 11.1% 90% 97.9%
▪ No 88.7% 93% 4.8% 88 n=35.9% 10% 2.1%
▪ NO/NI n =9 n=14 n=29 n=41 n =24
Previous surgery
▪ Bariatric 78.6% 87.8% 81.6% 96.6% 100% 95.5%
▪ Oncologic 75% 71.4% 84.2% 72.4% 25.9% 59.1%
▪ NO/NI n =15 n=22 n=33 n=42 n=44 n =27
EID, endoscopic internal drainage; EVT, endoscopic vacuum therapy; OTSC, over-the-scope clip; NO/NI, no experience/no information
1 Final percentage may be higher than 100% as many respondents considered more than one option.
More than 
40
7 % (n = 5)
27 % (n = 19)
31 % (n = 22)
23 % (n = 16)
13 % (n = 9)









▶ Fig. 2 Respondents’ answers to how many patients with anasto-
motic leaks does your therapeutic endoscopy unit usually treat in
1 year.
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SEMS). The majority (80%) used techniques to minimize stent
migration, with 38% (n=21) of them using combined thera-
pies; placement of PC-SEMS is usually the preferred technique
(45%), followed by suture of the stent to the mucosa (33%)
and anchoring the stent with TTS clips (25%) or OTSC (16%).
Additional techniques to minimize stent migration are con-
sidered in patients with previous stent migration (52%), if in-
complete sealing between stent and esophageal wall (34%)
and when stents placed across jejunal anastomoses (19%)
(▶Table 3).
The most common stent dwell time reported was 4 weeks
(49%) (range: 2–10 weeks) (▶Table3).
Patients with acute leaks (94%), without associated collec-
tions (89%), with intra-thoracic location (93%) and less than
3 cm in diameter were considered ideal for stent placement;
the majority of respondents considered both previous surger-
ies (bariatric or oncologic) suitable for stent placement (▶Ta-
ble2).
Over-the-scope clips
Sixty-six percent and 37% of the 64 participants with OTSC ex-
perience reported placing them in acute and early leaks,
respectively; 17% reported always performing epithelial abla-
tion/damage prior to OTSC application, with 62% performing
it at least in half of procedures (▶Table 3).
Patients without associated collections (93%), with intra-ab-
dominal location (92%), up to 1 cm in diameter (77%) and re-
sulting from previous bariatric surgery (88%) were considered
ideal patients for OTSC placement (▶Table2).
Endoscopic vacuum therapy
Seventy-five percent of the 40 respondents with EVT experi-
ence reported changing the polyurethane sponge every 3 to 5
days; 72% applied similar negative pressure for intra-thoracic
and intra-abdominal leaks. Most commonly, negative pressures
from 70 to 100mm Hg (41%) and 100 to 125mm Hg (~35%)
were used (▶Table4).
Regarding patients with large cavities but small leak de-
fects, 56% performed balloon dilation and intracavitary EVT,
while 28% placed the sponge intraluminally; 37% considered
stent-over-sponge if difficulties in directing the vacuum force
towards the leak, while 37% considered it to seal the sponge
from the gastrointestinal lumen (▶Table4).
Patients with chronic leaks (72%), with associated collec-
tions (95%), with intra-thoracic location (92%) and with more
than 2 cm in diameter were considered ideal for EVT therapy;
the majority of respondents considered both previous surgeries
suitable for EVT (▶Table2).
Endoscopic suture
Thirty-six percent of 36 respondents with suturing experience
reported always performing epithelial ablation/damage prior
to suturing, while 61% performed it in at least half of proce-
dures (▶Table3).
Patients with acute leaks (89%), without associated collec-
tions (89%), up to 2 cm in diameter, with intra-abdominal loca-
tion (97%) and resulting from previous bariatric surgery (97%)
were considered ideal for endoscopic suturing (▶Table2).
0 % 20 %
21 % (n = 15)
21 % (n = 15)
27 % (n = 19)
24 % (n = 17)
35 % (n = 25)
97 % (n = 69)
52 % (n = 37)
56 % (n = 40)
63 % (n = 45)
89 % (n = 63)
79 % (n = 56)
76 % (n = 54)













▶ Fig. 3 Respondents’ answers to techniques available in endoscopic departments.
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▶ Table 3 Respondents’ answers to opinion probing questions regarding primary closure techniques.
Technique Question Answer %
Stents1 Self-expandable stent– first option Fully-covered 56.5%
Partially-covered 42%
Plastic 1.4%
Techniques to minimize stent migration





When to use additional techniques to minimize
stent migration?
Patients with previous stent migration 52.2%










Time limit between leak and OTSC placement < 7 days (acute leaks) 65.6%
1 to 6 weeks (early leaks) 37.5%
6 to 12 weeks (late leaks) 6.3%
> 12 weeks (chronic leaks) 9.4%
Not relevant 20.3%
Epithelial ablation prior to OTSC placement Always 17%
> 90% of the cases 20.8%
75% to 90% of the cases 13.2%
50% to 75% of the cases 11.3%




Epithelial ablation prior to suture Always 36.1%
> 90% of the cases 16.7%
75% to 90% of the cases 5.6%
50% to 75% of the cases 2.8%
< 50% of the cases 25%
Never 13.9%
OTSC, over-the-scope clip; PC-SEMS,partially covered self-expandable metal stent; TTS, through-the-scope
1 Two to four endoscopists reported no experience with stents placement.
2 Seven to 18 respondents reported no experience with OTSC placement.
3 Thirty-five respondents reported no experience with endoscopic suture.
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Endoscopic septotomy
Fifty-six percent of the 32 respondents with septotomy experi-
ence reported that the minimal time interval from surgery
should be 4 weeks; 53% considered that limits of septotomy
should be defined on a case-by-case basis. Regarding patients
with previous sleeve gastrectomy, 13% always performed addi-
tional balloon dilation, while 81% only performed it if associat-
ed transgastric hyper-pressure. Ninety percent considered the
need to perform further septotomy sessions, with presence of
residual septum (50%) and incomplete drainage (30%) being
the main indications; a median of 11 days (6–35) between
treatments was reported (▶Table 4).
Patients with chronic leaks (100%), with associated collec-
tions (90%), with intra-abdominal location (93%) and resulting
from previous bariatric surgery (100%) were considered the
ideal patients for endoscopic septotomy; all leak sizes were
considered amenable to endoscopic septotomy (▶Table2).
Endoscopic internal drainage
The majority of respondents with EID experience reported pre-
ferring placement of two plastic stents (82% of 45) and shorter
stents (62% of 21) for drainage; 30% of 56 respondents referred
to never performing necrosectomy. A median of 14 days (1–
90) between stents exchange was reported. A median of 4.5
days (0–42) until oral diet resumption was reported, with 21%
of respondents (n=9) starting the day of procedure or day after
(▶Table 4).
Patients with chronic leaks (65%), with associated collec-
tions (97%), with intra-abdominal location (83%), up to 2 cm
in diameter and resulting from previous bariatric surgery
(95 %) were considered ideal for endoscopic internal drainage
(▶Table 2).
Endoscopic failure
Persistent inflammation with clinical sepsis (55%) was the defi-
nition most commonly reported for endoscopic failure, fol-
lowed by inability to resume oral feeding (42%), duration of
treatment (39%), chronic reepithelized fistula (37%), number
of endoscopic sessions (30%) and closure not achieved after 1
month of treatment with one single technique (28%).
Clinical cases
EVT was the therapeutic option most often chosen (27%) in
post Ivor-Lewis esophagectomy with an intra-thoracic associat-
ed collection (clinical case 1), followed by stent placement plus
drainage (23%) and stent placement (14%) (▶Fig. 4a); EVT and
EID were the therapeutic options most often chosen in post-
sleeve gastrectomy 2 cm in diameter (clinical case 2) and post
RYGB with an intraabdominal associated collection (clinical
case 3) (21% and 20%, respectively), followed by stent place-
ment plus drainage (17% and 14%) (▶Fig. 4b, ▶Fig. 4c); sur-
gery was the therapeutic option most often chosen in post total
gastrectomy (clinical case 4) (24%), followed by stent place-
ment with or without drainage (19%) (▶Fig. 4d).
Discussion
Therapeutic endoscopy plays a major role in management of
UGI anastomotic leaks, offering an effective treatment alterna-
tive to repeat surgery [10]. The available endoscopic approa-
ches range from primary to secondary closure techniques,
with varying degrees of technical and clinical success and ad-
verse events, generating a lack of consensus regarding the
most appropriate endoscopic management [11].
This survey shows that placement of stents, specifically
SEMS, is the technique most available and most frequently
used in almost every department. Even though OTSC are also
well-represented, they are not a common first option, as repre-
sented in the clinical cases section. This is probably related to
the need for pliable tissue for successful placement, as well as
risk of leak recurrence due to OTSC displacement [8, 12]. Other
reasons for failed closure may be related to poor integrity of the
tissue surrounding the leak as a result of ischemia and inflam-
mation as well as poor/partial placement over often large de-
fects. On the other hand, EID and EVT seem to be increasingly
used techniques; this is probably related to the fact that closing
leaks with tissue apposition techniques or diversion therapy
does not seem to be the ideal treatment strategy in some cases,
especially in late or chronic leaks. EVT and EID allow optimal
drainage of the cavity, ensuring granulation, utilizing the con-
cept of keeping the leak open [12].
The majority of participants considered that bariatric leaks
should be treated differently from oncologic leaks, with loca-
tion, size, chronicity, and associated cavity being the most rele-
vant leak characteristics. Need for additional percutaneous/sur-
gical drainage is almost always considered when closure tech-
niques (tissue apposition or diversion techniques) are chosen,
as internal drainage is not achieved, either by the collection
not being reachable (69%) or sealed (66%). All of these is re-
flected in clinical cases choices. EVT and stent placement, with
or without percutaneous/surgical drainage, were the therapeu-
tic options most often chosen in patients with previous oncolo-
gic surgery, while EVT and EID were the therapeutic options
most often chosen in patients with previous bariatric surgery.
Interestingly, surgery was the first option in post-total gastrect-
omy case (24% of respondents), despite no previous endo-
scopic treatment failure nor presence of uncontained leak.
This might be explained by the almost complete leak of the
anastomosis.
Regarding self-expandable stents, both FC (56%) and PC-
SEMS (42%) were similarly selected as first options, even in pa-
tients without previous stent migration; besides PC-SEMS, 35%
of respondents used other additional techniques to minimize
stent migration (in patients without previous stent migration),
with endoscopic suturing of FC-SEMS being the preferred tech-
nique, as it seems to lower rates of stent migration [13]. Opti-
mal duration of stent dwell is unknown and is likely related to
leak classification and size as well as patient-related factors
[14]. Stent dwell time ranged from 4 to 6 weeks in 77% of re-
spondents.
Regarding endoscopic suturing, respondents believed it pro-
vides the ability to close larger defects than OSTC (2 cm versus
Rodrigues-Pinto Eduardo et al. International multicenter expert… Endoscopy International Open 2019; 07: E1671–E1682 E1677
▶ Table 4 Respondents’ answers to opinion probing questions regarding secondary closure techniques.
Technique Question Answer %
Endoscopic
vacuum therapy1
Approach in patients with large
cavities but small leak defects
Intraluminal EVT 28.2%
Balloon dilation and intracavitary EVT 56.4%
EVT plus stent 15.4%
How often change sponge in EVT <3 days 5%
Every 3 to 5 days 75%
Every 5 to 7 days 15%
Case by case 5%
Negative pressure for intra-
thoracic/intra-abdominal leaks
< 70mm Hg 16.2%
70mm to 100mm Hg 40.5%
100mm to 125mm Hg 35.9%/35.1%
>125mm Hg 7.7%/8.1%
When stent-over-sponge If difficulties in directing vacuum force towards the leak 36.7%




When perform additional balloon
dilation
If associated transgastric hyper-pressure (stricture/twist) 80.6%
Always 12.9%
Never 6.5%





Limits of septotomy Cavity length behind septum 47.1%
Case-by-case 52.9%
Need for further sessions Yes 90%
No 10%
When further situations Leak clearance 30%
Residual septum 50%
If cavity is not healing 5%
Larger collections 15%
Time between sessions Median, range (n =20) 11 days (6–35)
Endoscopic
internal drainage3
When to perform necrosectomy Always 5.4%
If presence of necrosis 64.3%
Never 30.4%
Which stents Number Single 11.1%
Double 82.2%
One or the other 6.7%
Length Shorter 61.9%
Longer 33.3%
One or the other 4.8%
Time between sessions Median, range (n =47) 14 days (1–90)
Time until oral diet resumption Median, range (n =42) 4.5 days (0–42)
End of treatment 12.5%
EVT, endoscopic vacuum therapy
1 Thirty-one to 41 endoscopists reported no experience with EVT.
2 Seven to 41 endoscopists reported no experience with endoscopic septotomy.
3 Five to 29 endoscopists reported no experience with endoscopic internal drainage.
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▶ Fig. 4 Respondents’ answers to clinical cases section.
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1 cm). Both require robust mucosa to hold the sutures when tis-
sue is pulled in apposition [8]; epithelial ablation/damage to the
defect edges before OTSC or suturing may increase procedure
success and result in a more durable seal, with ~60% of respon-
dents performing it in more than half of procedures.
Regarding EVT, sponges can be placed intracavitary and/or
intraluminal, depending on the defect size and presence of an
extraluminal cavity [1]. Even though intraluminal EVT might
be easier and safer than intracavitary EVT [12], the majority
(56%) of respondents preferred to perform balloon dilation
and intracavitary EVT, as leak closure might be better [12].
One of the great disadvantages of EVT is the need for repeat
endoscopic procedures, as the majority of respondents (90%)
changed the polyurethane sponge every 3 to 5 days or 5 to 7
days.
Similar to peripancreatic collections drainage, an organized
walled-off collection must be established for endoscopic sep-
totomy to be safe and effective. This was reflected by the ma-
jority of respondents (56%), who only consider it at least 4
weeks after surgery. Management of the downstream stenosis
within the sleeve that creates an unfavorable pressure gradient
was also considered critical to enhance drainage and correction
of one of the underlying physiologic defects that predisposed
and perpetuated the leak. Need for repeated septotomy (90%)
was mostly based on presence of residual septum (50%) or in-
complete clearance of the cavity (30%).
Although EID with transgastric stents appears to be effec-
tive, controversies exist regarding optimal technique [15].
Even though necrosectomy may expedite clinical improvement,
30% of respondents reported never doing it. A median of 4.5
days until oral diet resumption was reported, with 21% starting
it the day of or after procedure, as it is believed oral contents do
not enter the perigastric cavity. Regarding stent exchange,
while some saw no value in routine stent exchange unless ne-
crosectomy was also performed [15], performance of multiple
procedures may allow to evaluate treatment progression to
adapt internal drainage, as well as promote healing by inducing
trauma in the pseudocavity with exchange of the pigtail stents
[16].
As there are no comparative studies between the different
endoscopic techniques, it is difficult to establish a therapeutic
algorithm in these patients. Determining optimal therapy for
such patients requires careful examination of patient clinical
status, anastomotic defect, and a review of all available op-
tions, local expertise, and previous experience. The approach
to UGI anastomotic leaks should always be individualized and
multidisciplinary. Considering the majority of respondents’ an-
swers, acute and small leaks without associated collections may
be considered for stent placement (up to 3 cm), OSTC place-
ment (up to 1 cm) or endoscopic suture (up to 2 cm). In the set-
ting of associated collection, these techniques can still be con-
sidered if external drainage is also performed; if not, EVT, EID
and endoscopic septotomy should be considered, with EVT
and EID being an option in acute and chronic leaks, while endo-
scopic septotomy should only be performed in leaks with more
than 4 weeks’ duration. While endoscopic septotomy can be
considered for all leak sizes, EID is ideal for leaks up to 2 cm
and EVT for leaks larger than 2 cm. Intrathoracic leaks may be
better served with stents or EVT, and intraabdominal leaks
with OTSC, suturing, septotomy or EID. Leaks resulting from
previous bariatric surgery should ideally be treated with OTSC,
suture, septotomy or EID, while stents and EVT can be consid-
ered for leaks related to bariatric and oncologic surgeries.
Conclusion
In conclusion, this study provides an overview of the techniques
used for endoscopic management of UGI leaks and shows that
there is wide variation in management of patients with UGI ana-
stomotic leaks, even among the most expert in the field, parti-
cularly concerning difficult-to-treat patients, possibly reflect-
ing the poor quality of evidence available at the moment. Lim-
itations of our study include a survey response rate of only 44%
which may subject the study to bias, making interpretation of
results more challenging. However, this study presents infor-
mation which to date has not been available, with inclusion of
experts from various countries, different opinion questions re-
garding each technique, and different clinical scenarios. Even
though there is no consensus on the definition of endoscopic
failure, persistent inflammation with clinical sepsis and impos-
sibility to resume oral feeding should be strongly considered.
Future prospective studies should address these issues, and for
which transnational collaborations are urgently needed, so that
we move from an expert- to an evidence- and personalization-
based care in endoscopic treatment of upper anastomotic
leaks.
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